Advisory Board

The ePA National Adoption Scorecard is written and published by CoverMyMeds with guidance from industry experts on the ePA National Adoption Scorecard Advisory Board:

  1. Lee Ann Stember

    President & CEO, NCPDP

  2. Rebecca Snead

    EVP & CEO, National Alliance of State Pharmacy Associations

  3. Judy Sorio

    Director, Cerner

  4. Joel White

    President & CEO, Horizon Government Affairs

  5. Robert Nace

    VP, Specialty Industry Relations, OptumRx

  1. Nick Calla

    VP, Industry Relations, Cardinal Health

  2. RADM (ret) Pam Schweitzer Pharm.D., BCACP

    10th Chief Pharmacist Officer, USPHS, Consultant

  3. Lynne Nowak, MD

    VP, Clinical & Provider Strategy, Express Scripts

  4. Rita Russell

    Senior Director, Relationship Management, RelayHealth Pharmacy Solutions

Sources

  1. 1 - CoverMyMeds data on file, 2018
  2. 2 - Payer data collated by CoverMyMeds, 2018
  3. 3 - CoverMyMeds data on file, 2018
  4. 4 - 2018 Real-time Benefit Check National Adoption Scorecard
  5. 5 - The Global Use of Medicine in 2019 and Outlook to 2023
  6. 6 - CoverMyMeds Analytics (Based on two months of paid and rejected data from PioneerRx. Data only considers reject codes 70,75, and MR.)
  7. 7 - CoverMyMeds data on file – effect of PA completion channel on turnaround time, 2018
  8. 8 - CoverMyMeds data on file – effect of ePA turnaround time on dispense rate, 2018
  9. 9 - Express Scripts data on file
  10. 10 - Medicines Use and Spending in the U.S., 2017
  11. 11 - CoverMyMeds Direct-to-Provider Survey, 2018
  12. 12 - Point-of-Care Partners, ePrescribing (eRX) of Specialty Medication — Where We are and Where We’re Going
  13. 13 - CMS data: CY Specialty Tier Methodology
  14. 14 - The Drug Channels Institute, The 2018 – 2019 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
  15. 15 - The Drug Channels Institute, Future Vision: The Top 10 Drugs of 2020
  16. 16 - CoverMyMeds denial data for specialty drugs, 2016
  17. 17 - CVS Health Specialty Solutions, Managing Specialty Drug Spend Under the Medical Benefit
  18. 18 - CoverMyMeds in-depth research, 2018
  19. 19 - CoverMyMeds data on file, 2018
  20. 20 - CoverMyMeds in-depth research, 2018
  21. 21 - CoverMyMeds Analytics, 2018
  22. 22 - H.R.6 – Support for Patients and Communities Act
  23. 23 - CoverMyMeds Government Affairs Team, 2018
  24. 24 - Magellan Rx Management: Medicaid Pharmacy Trend Report 2017 Second Edition
  25. 25 - Individuals Enrolled - November 2017 Medicaid and CHIP Enrollment Data Highlights
  26. 26 - CoverMyMeds in-depth research, 2018
  27. 27 - CoverMyMeds in-depth research, 2018
  28. 28 - CoverMyMeds in-depth research, 2018
  29. 29 - Epic Health System data, 2016
  30. 30 - CoverMyMeds in-depth research, 2018
  31. 31 - Agency for Healthcare and Research Quality, Snapshots of U.S. Health Systems, 2016
  32. 32 - CoverMyMeds data on file, 2018
  33. 33 - CoverMyMeds data on file, 2018
  34. 34 - CoverMyMeds data on file, 2018
  35. 35 - CoverMyMeds data on file, 2018
  36. 36 - CoverMyMeds data on file, 2018
  37. 37 - CoverMyMeds data on file, 2018
  38. 38 - CoverMyMeds data on file, 2018
  39. 39 - CoverMyMeds data on file, 2018
  40. 40 - Payer data collated by CoverMyMeds, 2018
  41. 41 - CoverMyMeds payer case study, 2018
  42. 42 - CoverMyMeds case study, 2017
  43. 43 - CoverMyMeds data on file, 2018
  44. 44 - CoverMyMeds data on file, 2018
  45. 45 - CoverMyMeds data on file, 2018
  46. 46 - CoverMyMeds in-depth research, 2018